13F Data
13F filer · CIK 1600004

First Light Asset Management, LLC

Edina, MN · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$1.6B
+$529.4M vs prior
Positions
31
New / sold out
2 / 6
Added / reduced
17 / 12
Turnover
17.3%
buys $391.4M · sells $239.1M
Top-10 weight
60.7%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedENLIVEN THERAPEUTICS INC+1,158,883+574.1%+$58.8M
AddedAPOGEE THERAPEUTICS INC+353,605+61.3%+$46.9M
AddedSI-BONE INC+2,774,795+51.8%+$45.3M
NewTREVI THERAPEUTICS INC+2,097,215–+$39.1M
AddedNEOGENOMICS INC+2,549,545+26.2%+$37.2M
AddedGENEDX HOLDINGS CORP+540,996+222.7%+$37.1M
AddedTANDEM DIABETES CARE INC+2,068,838+157.4%+$31.2M
AddedGUARDANT HEALTH+161,287+57.5%+$24.2M
NewTACTILE SYSTEMS TECHNOLOGY INC+462,562–+$13.8M
AddedVAXCYTE INC+203,373+143.4%+$11.8M
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outCENTESSA PHARMACEUTICALS LIMITED-1,560,991-100.0%$-62.0M
ReducedAXOGEN INC-1,254,407-31.3%$-57.9M
ReducedPALVELLA THERAPEUTICS INC-208,857-21.3%$-31.9M
ReducedTWIST BIOSCIENCE CORPORATION-150,915-17.2%$-15.5M
Sold outWAVE LIFE SCIENCES LTD-1,843,968-100.0%$-13.4M
Sold outVERA THERAPEUTICS INC-313,906-100.0%$-12.6M
Sold outMIMEDX GROUP INC-2,842,892-100.0%$-11.2M
Sold outSPYGLASS PHARMA INC-375,000-100.0%$-9.7M
Sold outORGANOGENESIS HOLDINGS INC-3,498,533-100.0%$-8.3M
ReducedESTABLISHMENT LABS HOLDINGS-61,161-19.9%$-5.2M
8 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $117.9MQ1 2014: $141.2MQ2 2014: $148.4MQ3 2014: $146.2MQ4 2014: $176.5MQ1 2015: $195.8MQ2 2015: $212.5MQ3 2015: $202.4MQ4 2015: $238.8MQ1 2016: $198.2MQ2 2016: $215.9MQ3 2016: $232.3MQ4 2016: $227.5MQ1 2017: $261.9MQ2 2017: $298.1MQ3 2017: $315.8MQ4 2017: $364.7MQ1 2018: $455.4MQ2 2018: $642.3MQ3 2018: $619.8MQ4 2018: $627.2MQ1 2019: $769.6MQ2 2019: $720.2MQ3 2019: $661.5MQ4 2019: $782.3MQ1 2020: $585.8MQ2 2020: $858.2MQ3 2020: $976.0MQ4 2020: $1.4BQ1 2021: $1.5BQ2 2021: $1.7BQ3 2021: $1.5BQ4 2021: $1.4BQ1 2022: $1.1BQ2 2022: $859.4MQ3 2022: $988.1MQ4 2022: $1.1BQ1 2023: $1.1BQ2 2023: $1.3BQ3 2023: $1.1BQ4 2023: $1.2BQ1 2024: $1.3BQ2 2024: $1.1BQ3 2024: $1.2BQ4 2024: $1.0BQ1 2025: $875.7MQ2 2025: $771.3MQ3 2025: $1.1BQ4 2025: $1.3BQ1 2026: $1.1BQ2 2026: $1.6B
Q4 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1NEOGENOMICS INCCOMMON STOCKS12,279,523$179.2M10.89%
2SI-BONE INCCOMMON STOCKS8,127,985$132.6M8.06%
3AXOGEN INCCOMMON STOCKS2,748,361$126.9M7.72%
4APOGEE THERAPEUTICS INCCOMMON STOCKS930,289$123.5M7.50%
5PALVELLA THERAPEUTICS INCCOMMON STOCKS771,901$118.0M7.17%
6TWIST BIOSCIENCE CORPORATIONCOMMON STOCKS727,933$74.9M4.55%
7ENLIVEN THERAPEUTICS INCCOMMON STOCKS1,360,750$69.1M4.20%
8GUARDANT HEALTHCOMMON STOCKS441,586$66.3M4.03%
9908 DEVICES INCCOMMON STOCKS6,282,804$54.7M3.32%
10AMYLYX PHARMACEUTICALS INCCOMMON STOCKS3,023,256$54.3M3.30%
21 more rows. Subscribe for $29/month to see every row, download the data and use the API.